HomeAnalyzeCompareBlog
NVDA

Health

100/100

NVIDIA Corporation

Key metrics

P/E

27.5

P/B

26.94

ROE

117.2%

Debt/Eq.

17

Margin

63.7%

Growth

88.3%

This is just a summary.

Get the full recommendation

Access the full analysis: RSI, Monte Carlo, supports and resistances.

Analyze NVDA now

Strengths

  • +Exceptional ROE (117.2%) — possibly amplified by buybacks
  • +High profit margin (63.7%)
  • +High gross margin (competitive advantage) (74.7%)
  • +Solid operating margin (66.2%)
  • +Low debt
  • +Excellent liquidity
  • +Strong revenue growth (88.3%)

Weaknesses

  • High P/B
  • High P/FCF (expensive vs real cash flow)
  • High EV/EBITDA (expensive enterprise valuation)

This analysis is educational and informational. It does not constitute financial advice. How we calculate this